# Email Send Priority Order

**Based on:** Validation strength, claim accuracy, and risk of embarrassment

**Last Updated:** 2026-01-26

---

## WAVE 1: SEND IMMEDIATELY (Strongest Validation)

### Arbovirus Researchers (15 emails)
**Why first:** Novel discovery, multiple validation approaches, no overstated claims

| # | Recipient | Email Status | Notes |
|:-:|-----------|:------------:|-------|
| 4 | Scott Weaver | âœ… Ready | UTMB arbovirus authority |
| 13 | Eva Harris | âœ… Ready | Berkeley dengue expert |
| 14 | Nikos Vasilakis | âœ… Ready | UTMB, DENV evolution |
| 15 | Trevor Bedford | âœ… Ready | Fred Hutch, viral phylogenetics |
| 46 | Kristian Andersen | ğŸ” Research | Scripps, viral genomics |
| 47 | Oliver Pybus | ğŸ” Research | Oxford, phylodynamics |
| 48 | Andrew Rambaut | âœ… Ready | Edinburgh, BEAST author |
| 49 | Eddie Holmes | âœ… Ready | Sydney, viral evolution |
| 50 | Marco Vignuzzi | âœ… Ready | Pasteur, viral dynamics |
| 54 | Nathan Grubaugh | âœ… Ready | Yale, arbovirus surveillance |
| 55 | Pardis Sabeti | âœ… Ready | Broad, outbreak genomics |
| 56 | Jesse Bloom | âœ… Ready | Fred Hutch, viral evolution |
| 57 | Sarah Cobey | âœ… Ready | Chicago, pathogen evolution |
| 58 | Michael Worobey | âœ… Ready | Arizona, viral origins |
| 60 | Anavaj Sakuntabhai | âœ… Ready | Pasteur, dengue genetics |

**Key claim:** "DENV-4 has 71.7% within-serotype identity vs 95-98% for other serotypes"
**Validation:** âœ… Fully validated with multiple orthogonal approaches

---

### Hyperbolic/P-adic ML Researchers (16 emails)
**Why first:** Theoretical claims are sound, no biological claims to verify

| # | Recipient | Email Status | Notes |
|:-:|-----------|:------------:|-------|
| 16 | Christopher De Sa | âœ… Ready | Cornell, p-adic ML |
| 86 | Max Nickel | âœ… Ready | Meta FAIR, PoincarÃ© embeddings inventor |
| 87 | Frederic Sala | âœ… Ready | UW-Madison, hyperbolic ML |
| 88 | Ines Chami | âœ… Ready | Stanford, hyperbolic GNNs |
| 89 | Octavian Ganea | âœ… Ready | NYU, hyperbolic embeddings |
| 90 | Michael Bronstein | âœ… Ready | Oxford, geometric DL |
| 91 | Jure Leskovec | âœ… Ready | Stanford, graph ML |
| 92 | Chris Re | âœ… Ready | Stanford, ML systems |
| 93 | Albert Gu | âœ… Ready | CMU, state space models |
| 95 | v-PuNNs Author | âœ… Ready | P-adic neural networks |
| 97 | Geomstats Maintainers | âœ… Ready | Open source, GitHub |
| 98 | Geoopt Maintainers | âœ… Ready | Open source, GitHub |
| 99 | Shun-ichi Amari | âœ… Ready | RIKEN, information geometry |
| 100 | Eugene Koonin | âœ… Ready | NIH, evolutionary biology |

**Key claim:** "P-adic valuation + PoincarÃ© embeddings for biological sequences"
**Validation:** âœ… Mathematical framework sound, downstream results demonstrated

---

### VAE/Generative Researchers (5 emails - theoretical)
| # | Recipient | Email Status | Notes |
|:-:|-----------|:------------:|-------|
| 7 | Debora Marks | âœ… Ready | Harvard, EVcouplings |
| 76 | Namrata Anand | âœ… Ready | Stanford, protein generation |
| 78 | Rama Ranganathan | âœ… Ready | Chicago, SCA |
| 84 | EvolutionaryScale | âœ… Ready | ESM team |
| 85 | Insilico Medicine | âœ… Ready | AI drug discovery |

---

## WAVE 2: SEND AFTER MINOR EDITS

### Protein Stability / DDG Researchers (19 emails)
**Edit required:** Add "N=52 curated subset" caveat

| # | Recipient | Email Status | Edit Needed |
|:-:|-----------|:------------:|:-----------:|
| 1 | Brian Kuhlman | âœ… Ready | Add N caveat |
| 5 | Kresten Lindorff-Larsen | âœ… Ready | Add N caveat |
| 6 | David Baker | âœ… Ready | Add N caveat |
| 8 | Mohammed AlQuraishi | âœ… Ready | Add N caveat |
| 9 | Sergey Ovchinnikov | âœ… Ready | Add N caveat |
| 17 | Tanja Kortemme | âœ… Ready | Add N caveat |
| 18 | Haipeng Gong | âœ… Ready | Add N caveat |
| 19 | Frances Arnold | âœ… Ready | Add N caveat |
| 20 | George Church | âœ… Ready | Add N caveat |
| 21 | Philip Kim | ğŸ” Research | Add N caveat |
| 22 | Mauno Vihinen | âœ… Ready | Add N caveat |
| 23 | Possu Huang | âœ… Ready | Add N caveat |
| 24 | Amelie Stein | âœ… Ready | Add N caveat |
| 25 | Russ Altman | âœ… Ready | Add N caveat |
| 26 | Kevin Yang | ğŸ” Research | Add N caveat |
| 28 | Bonnie Berger | âœ… Ready | Add N caveat |
| 29 | Dana Pe'er | âœ… Ready | Add N caveat |
| 30 | Brian Hie | âœ… Ready | Add N caveat |

**Key edit:** Change "12 of 52 cases" to "12 of 52 cases in our curated alanine-scanning subset"

---

## WAVE 3: SEND AFTER SCOPE CLARIFICATION

### Antimicrobial Peptides Researchers (15 emails)
**Edit required:** Clarify E. coli focus, remove all-pathogen implication

| # | Recipient | Email Status | Edit Needed |
|:-:|-----------|:------------:|:-----------:|
| 2 | Cesar de la Fuente | âœ… Ready | Clarify E. coli scope |
| 10 | Robert Hancock | âœ… Ready | Clarify E. coli scope |
| 31 | William Wimley | âœ… Ready | Clarify scope |
| 32 | Artem Cherkasov | âœ… Ready | Clarify scope |
| 33 | Miguel Castanho | âœ… Ready | Clarify scope |
| 34 | Hilal Lashuel | âœ… Ready | Clarify scope |
| 35 | Anne-Marie Krachler | âœ… Ready | Clarify scope |
| 36 | DRAMP Database | âœ… Ready | Clarify scope |
| 37 | APD3 Database | âœ… Ready | Clarify scope |
| 38 | DBAASP Database | âœ… Ready | Clarify scope |
| 40 | Glasgow AMP Team | âœ… Ready | Clarify scope |
| 43 | AMPGAN Authors | âœ… Ready | Clarify scope |
| 44 | PyAMPA Authors | âœ… Ready | Clarify scope |

**Key edit:** Change "MIC prediction" to "MIC prediction for E. coli (Ï=0.39, p<0.001) and general datasets"

---

## WAVE 4: READY TO SEND (API Verified 2026-01-26)

### HIV Researchers (18 emails)
**Status:** Stanford HIVdb API verified working (v10.1, published 2026-01-18)

| # | Recipient | Email Status | Notes |
|:-:|-----------|:------------:|:------|
| 3 | Robert Shafer | âœ… Ready | HIVdb maintainer - ask guidance |
| 11 | Daniel Kuritzkes | âœ… Ready | Clinical resistance expert |
| 12 | HIVdb Team | âœ… Ready | Technical collaboration |
| 61 | John Mellors | âœ… Ready | Resistance pioneer |
| 62 | Roger Paredes | âœ… Ready | IrsiCaixa, NGS resistance |
| 63 | Ravi Gupta | âœ… Ready | Cambridge/Crick, resistance |
| 64 | Francois Clavel | âœ… Ready | INSERM, RT structure |
| 67 | IAS | âœ… Ready | Organization outreach |
| 68 | UNAIDS | âœ… Ready | Public health angle |
| 69 | amfAR | âœ… Ready | Foundation outreach |
| 70 | Art Poon | âœ… Ready | Sierra-local author |

**API Verified:** GraphQL endpoint responds, sequence analysis works, drug scores returned

---

## WAVE 5: LOW PRIORITY

### Industry / Generic Contacts
| # | Recipient | Notes |
|:-:|-----------|-------|
| 27 | AlphaFold Team (DeepMind) | Generic inbox, low response expected |
| 51 | CADDE Centre | ğŸ” Need specific contact |
| 52 | PAHO Arbovirus | Regional office |
| 53 | CDC Dengue Branch | ğŸ” Need specific contact |
| 65 | ViiV Healthcare | ğŸ” Industry, need warm intro |
| 66 | Gilead HIV | ğŸ” Industry, need warm intro |
| 79 | NVIDIA BioNeMo | Industry |
| 80 | Meta FAIR Biology | Industry |

---

## Summary

| Wave | Category | Count | Status | Timeline |
|:----:|----------|:-----:|:------:|----------|
| 1 | Arbovirus + Hyperbolic/P-adic + VAE | 36 | âœ… Ready | Send now |
| 2 | Protein DDG | 19 | âš ï¸ Edit | After N caveat added |
| 3 | AMP | 15 | âš ï¸ Edit | After scope clarified |
| 4 | HIV | 18 | âœ… Ready | API verified 2026-01-26 |
| 5 | Industry/Generic | 12 | â¸ï¸ Low | Last priority |

**Recommended daily pace:** 5-10 emails per day, staggered by timezone

---

*Review VALIDATION_CHECKLIST.md before each wave.*
